Abstract
Sclerotherapy consists of intravenous injection of sclerosing agents for the treatment of cosmetic leg veins. Several studies have reported that sclerotherapy has been successfully used for the treatment of minor branch vein varicosities not associated with saphenous incompetence.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Iannitti T, Rottigni V, Torricelli F, Palmieri B. Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study. Clin Appl Thromb Hemost. 2014;20(3):326–30.
Scott C, Seiger E. Postsclerotherapy pigmentation. Is serum ferritin level an accurate indicator? Dermatol Surg. 1997;23(4):281–2.
Subbarao NT, Aradhya DD, Veerabhadrappa NH. Sclerotherapy in the management of varicose veins and its dermatological complications. Indian J Dermatol Venereol Leprol. 2013;79(3):383–8.
Zaulyanov-Scanlan L. Sclerotherapy. In: Bauman L, editor. Cosmetic dermatology: principles and practice. 2nd ed. New York, NY: McGraw-Hill; 2009.
Zummo MG. Cloutier’s sclerotherapy of varices. Phlebologie. 1991;44(1):37–43.
Further Reading
American Academy of Dermatology. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. J Am Acad Dermatol. 1996;34(3):523–8.
Bihari I, Magyar E. Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg. 2001;27(2):133–6.
Conrad P, Malouf GM, Stacey MC. The Australian polidocanol (Aethoxysklerol) study. Results at two years. Dermatol Surg. 1995;21(4):334–6.
Del Bianco E, Muscarella G, Cappugi P. Sclerotherapy. In: Katsambas AD, Lotti TM, editors. European handbook of dermatological treatment. 2nd ed. Berlin; New York, NY: Springer; 2003.
Goldman PM. Polidocanol (Aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol. 1989;15:204.
Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention and treatment. Dermatol Surg. 1995;21(1):19–29.
Green D. Sclerotherapy for the permanent eradication of varicose veins: theoretical and practical considerations. J Am Acad Dermatol. 1998;38:461–75.
Higgins TT, Kittel PB. The use of sodium morrhuate in treatment of varicose veins by injection. Lancet. 1939;1:68–9.
McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia – a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 1999;25(5):381–5.
Puissegur LML. Sclerotherapy: review of results and complications in 200 patients. J Dermatol Surg Oncol. 1989;15:214.
Tessari I, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27(1):58–60.
Weiss RA, Goldman MP. Advances in sclerotherapy. Dermatol Clin. 1995;13(2):431–45.
Weiss RA, Weiss MA. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs polidocanol. J Dermatol Surg Oncol. 1990;16:800.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Napoli, S., Zanardelli, M., D’Erme, A.M., Lotti, T.M. (2023). Sclerotherapy. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_129
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_129
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)